Baird lowered the firm’s price target on Healthpeak Properties (DOC) to $22 from $24 and keeps an Outperform rating on the shares. The firm updated its model following Q1 results where it appears the copany’s allocation will shift back to stock buybacks.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOC:
- Healthpeak Properties Approves Employee Stock Purchase Plan
- Healthpeak Properties price target lowered to $22 from $24 at Wedbush
- Healthpeak Properties Reports Strong Q1 2025 Results
- Healthpeak Properties’ Earnings Call Highlights Resilience Amid Challenges
- Healthpeak Properties: Strong Business Growth and Strategic Financial Moves Justify Buy Rating